, Singapore

Raffles Medical's profits down 45.4% to $7.5m in Q1

Profits were dragged down by the pandemic’s impact on its China units.

Raffles Medical Group’s profits for the first quarter of the decade fell 45.4% YoY to $7.5m from $13.5m in the previous year, dragged down by its China Healthcare Division that was “severely impacted” by the COVID-19 pandemic, the group revealed in a company update.

The group also reported a revenue of $128m for Q1 2020, down 3% YoY from $128.3m in Q1 2019. Earnings before interest, depreciation, taxes and amortization (EBITDA) slipped 12.7% to $20.6m for Q1 2020 as compared with an EBITDA of $23.6m for Q1 2019.

Excluding the results of the China Healthcare Division comprising Raffles Hospital Chongqing, Raffles China Clinics and Raffles Medical Hong Kong, the group’s profit after tax saw a 5.1% YoY decrease at $15.1m compared to $15.9m in Q1 2019.

Looking ahead, Raffles Medical Group noted the return of walk-in patients at select units of its China business as well as Singapore’s circuit breaker measures.

“As China begins its recovery, we are happy to see walk-in patients returning to our
Raffles Hospital Chongqing and clinics in Beijing, Nanjing and Shanghai. In Singapore, we look forward to the reduction of Covid-19 cases amongst the foreign workers and the end of the lockdown on 1 June 2020, when we can serve our patients face to face again,” said Kimmy Goh, company secretary at Raffles Medical Group. 

Join Singapore Business Review community
Join Singapore Business Review community
A NOTE FROM SINGAPORE BUSINESS REVIEW

Reaching the people who run Asia's businesses is harder than it used to be.

Inboxes are crowded. Attention is short. The executives you most want to reach — the founders, CFOs, and operators who actually move budgets — are the hardest to find through the usual channels. If you're building a company, a category, or a reputation, you already know this.

We've spent twenty years building the room they read. Singapore Business Review is where senior decision makers in Singapore and across Southeast Asia come for business coverage they can't get elsewhere — in print, online, and in person at the summits and roundtables we host across seven markets.

If you have something these readers should know about — a point of view worth publishing, a product worth their attention, an event worth their time — we'd like to hear what you're trying to do.